XML 15 R4.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating expenses    
Research and development $ 9,558 $ 7,915
General and administrative 8,193 10,119
Total operating expenses 17,751 18,034
Loss from operations (17,751) (18,034)
Other income (expense), net 1,253 15
Net loss (16,498) (18,019)
Other comprehensive income (loss)    
Foreign currency translation adjustment (1) 0
Comprehensive loss $ (16,499) $ (18,019)
Shares used in calculating net loss per common share - basic (in shares) 225,523,627 205,693,498
Shares used in calculating net loss per common share - diluted (in shares) 225,523,627 205,693,498
Net loss per share of common stock - basic (in USD per share) $ (0.07) $ (0.09)
Net loss per share of common stock - diluted (in USD per share) $ (0.07) $ (0.09)